Data / Form D filings / MIMEDX GROUP, INC.
MIMEDX GROUP, INC.: Form D filings
MIMEDX GROUP, INC., a biotechnology company in Marietta, GA, filed 4 Form D notices with the SEC between 2009 and 2016. The latest, on January 22, 2016, reports $4 million sold of an offering with no set size to 10 investors.
Find out what MIMEDX GROUP, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1775 W OAK COMMONS COURT, NE, Marietta, GA, 30062
- Phone
- (678) 384-6720
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- Over $100,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1376339
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 22, 2016 | New notice | Indefinite | $4,000,000 | Indefinite | 10 | Jan 13, 2016 | sec.gov |
| Nov 29, 2010 | New notice | $5,000,000 | $2,080,000 | $2,920,000 | 20 | Nov 15, 2010 | sec.gov |
| Nov 19, 2009 | New notice | $5,000,000 | $675,000 | $4,325,000 | 6 | Oct 30, 2009 | sec.gov |
| May 1, 2009 | New notice | $4,025,000 | $1,420,000 | $2,605,000 | 13 | Apr 7, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Larry W. Papasan | Director | |
| Neil S. Yeston | Director | |
| William C. Taylor | Executive Officer, Director | |
| Parker H. Petit | Executive Officer, Director | |
| Charles E. Knob | Director | |
| Charles R. Evans | Director | |
| J. Terry Dewberry | Director | |
| Alexandra O. Haden | Executive Officer | |
| Bruce L. Hack | Director | |
| Joseph G. Bleser | Director | |
| Michael J. Senken | Executive Officer |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Jan 18, 2016 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MIMEDX GROUP, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.